VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q71475964 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000042.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q71475964‏
024 ‎‡a 0000-0003-1443-9236‏ ‎‡2 orcid‏
024 ‎‡a 6701829002‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q71475964‏
100 0 ‎‡a Jose Luis Garcia Garmendia‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a J L García-Garmendía‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features‏
670 ‎‡a Author's Clinical and metabolic effects of two lipid emulsions on the parenteral nutrition of septic patients‏
670 ‎‡a Author's Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm‏
670 ‎‡a Author's [Continuity of medical care. Evaluation of a collaborative program between hospital and Primary Care]‏
670 ‎‡a Author's Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients‏
670 ‎‡a Author's Effects of three intravenous lipid emulsions on the survival and mononuclear phagocyte function of septic rats.‏
670 ‎‡a Author's Evaluation and closure of the series on methodology in Intensive Care Medicine‏
670 ‎‡a Author's Fulminant leptospirosis in a previously healthy man‏
670 ‎‡a Author's Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.‏
670 ‎‡a Author's Incidence and outcome of invasive candidiasis in intensive care units‏
670 ‎‡a Author's Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project.‏
670 ‎‡a Author's Initial Antifungal Strategy Reduces Mortality in Critically Ill Patients With Candidemia: A Propensity Score-Adjusted Analysis of a Multicenter Study.‏
670 ‎‡a Author's Interleukin 10 and Sepsis‏
670 ‎‡a Author's Interpretation of statistical results‏
670 ‎‡a Author's Metformin-induced lactic acidosis: Should we be more careful with renal dysfunction?‏
670 ‎‡a Author's Methodological update in Medicina Intensiva.‏
670 ‎‡a Author's Morphine Use in Acute Heart Failure and Limitation of Therapeutic Effort‏
670 ‎‡a Author's Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study.‏
670 ‎‡a Author's Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients‏
670 ‎‡a Author's [Patient satisfaction when seen in the Emergency room of San Juan de Dios del Aljarafe Hospital (Spain)]‏
670 ‎‡a Author's Política editorial de Medicina Intensiva‏
670 ‎‡a Author's Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia‏
670 ‎‡a Author's Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.‏
909 ‎‡a (orcid) 0000000314439236‏ ‎‡9 1‏
909 ‎‡a (scopus) 6701829002‏ ‎‡9 1‏
919 ‎‡a interpretationofstatisticalresults‏ ‎‡A Interpretation of statistical results‏ ‎‡9 1‏
919 ‎‡a metformininducedlacticacidosisshouldwebemorecarefulwithrenaldysfunction‏ ‎‡A Metformin-induced lactic acidosis: Should we be more careful with renal dysfunction?‏ ‎‡9 1‏
919 ‎‡a bacteremiaduetoacinetobacterbaumanniiepidemiologyclinicalfindingsandprognosticfeatures‏ ‎‡A Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features‏ ‎‡9 1‏
919 ‎‡a clinicalandmetaboliceffectsof2lipidemulsionsontheparenteralnutritionofsepticpatients‏ ‎‡A Clinical and metabolic effects of two lipid emulsions on the parenteral nutrition of septic patients‏ ‎‡9 1‏
919 ‎‡a comparisonofintravenousflecainidepropafenoneandamiodaroneforconversionofacuteatrialfibrillationtosinusrhythm‏ ‎‡A Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm‏ ‎‡9 1‏
919 ‎‡a continuityofmedicalcareevaluationofacollaborativeprogrambetweenhospitalandprimarycare‏ ‎‡A [Continuity of medical care. Evaluation of a collaborative program between hospital and Primary Care]‏ ‎‡9 1‏
919 ‎‡a criticalillnesspolyneuropathyriskfactorsandclinicalconsequencesacohortstudyinsepticpatients‏ ‎‡A Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients‏ ‎‡9 1‏
919 ‎‡a effectsof3intravenouslipidemulsionsonthesurvivalandmononuclearphagocytefunctionofsepticrats‏ ‎‡A Effects of three intravenous lipid emulsions on the survival and mononuclear phagocyte function of septic rats.‏ ‎‡9 1‏
919 ‎‡a treatmentofmultidrugresistantacinetobacterbaumanniiventilatorassociatedpneumoniavapwithintravenouscolistinacomparisonwithimipenemsusceptiblevap‏ ‎‡A Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.‏ ‎‡9 1‏
919 ‎‡a evaluationandclosureoftheseriesonmethodologyinintensivecaremedicine‏ ‎‡A Evaluation and closure of the series on methodology in Intensive Care Medicine‏ ‎‡9 1‏
919 ‎‡a treatmentofmultidrugresistantacinetobacterbaumanniiventilatorassociatedpneumonia‏ ‎‡A Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia‏ ‎‡9 1‏
919 ‎‡a fulminantleptospirosisinapreviouslyhealthyman‏ ‎‡A Fulminant leptospirosis in a previously healthy man‏ ‎‡9 1‏
919 ‎‡a politicaeditorialdemedicinaintensiva‏ ‎‡A Política editorial de Medicina Intensiva‏ ‎‡9 1‏
919 ‎‡a impactofadequateempiricalantibiotictherapyontheoutcomeofpatientsadmittedtotheintensivecareunitwithsepsis‏ ‎‡A Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.‏ ‎‡9 1‏
919 ‎‡a patientsatisfactionwhenseenintheemergencyroomof3juandediosdelaljarafehospitalspain‏ ‎‡A [Patient satisfaction when seen in the Emergency room of San Juan de Dios del Aljarafe Hospital (Spain)]‏ ‎‡9 1‏
919 ‎‡a incidenceandoutcomeofinvasivecandidiasisinintensivecareunits‏ ‎‡A Incidence and outcome of invasive candidiasis in intensive care units‏ ‎‡9 1‏
919 ‎‡a mortalityandtheincreaseinlengthofstayattributabletotheacquisitionofacinetobacterincriticallyillpatients‏ ‎‡A Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients‏ ‎‡9 1‏
919 ‎‡a incidenceandoutcomeofinvasivecandidiasisinintensivecareunitsicusineuroperesultsoftheeucandicuproject‏ ‎‡A Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project.‏ ‎‡9 1‏
919 ‎‡a mortalityandmorbidityattributabletoinadequateempiricalantimicrobialtherapyinpatientsadmittedtotheicuwithsepsisamatchedcohortstudy‏ ‎‡A Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study.‏ ‎‡9 1‏
919 ‎‡a initialantifungalstrategyreducesmortalityincriticallyillpatientswithcandidemiaapropensityscoreadjustedanalysisofamulticenterstudy‏ ‎‡A Initial Antifungal Strategy Reduces Mortality in Critically Ill Patients With Candidemia: A Propensity Score-Adjusted Analysis of a Multicenter Study.‏ ‎‡9 1‏
919 ‎‡a morphineuseinacuteheartfailureandlimitationoftherapeuticeffort‏ ‎‡A Morphine Use in Acute Heart Failure and Limitation of Therapeutic Effort‏ ‎‡9 1‏
919 ‎‡a interleukin10andsepsis‏ ‎‡A Interleukin 10 and Sepsis‏ ‎‡9 1‏
919 ‎‡a methodologicalupdateinmedicinaintensiva‏ ‎‡A Methodological update in Medicina Intensiva.‏ ‎‡9 1‏
996 ‎‡2 DNB|1157191827‏
996 ‎‡2 BNE|XX1720168‏
996 ‎‡2 BNE|XX922691‏
996 ‎‡2 ISNI|0000000045264131‏
996 ‎‡2 NTA|069875499‏
996 ‎‡2 NSK|000558991‏
996 ‎‡2 J9U|987007453965405171‏
996 ‎‡2 SUDOC|258120800‏
996 ‎‡2 BNE|XX1071594‏
996 ‎‡2 BNC|981060918557606706‏
996 ‎‡2 BNCHL|10000000000000000089212‏
996 ‎‡2 BNE|XX1038178‏
996 ‎‡2 SUDOC|152302964‏
996 ‎‡2 LC|n 82137994‏
996 ‎‡2 LC|n 86047104‏
996 ‎‡2 BNC|981058581223306706‏
996 ‎‡2 DNB|1157309984‏
996 ‎‡2 SUDOC|055334202‏
996 ‎‡2 NKC|jo20201075447‏
996 ‎‡2 NII|DA12911763‏
996 ‎‡2 BNCHL|10000000000000000048170‏
996 ‎‡2 LC|ns2015001079‏
996 ‎‡2 SUDOC|029437059‏
996 ‎‡2 BNF|16735683‏
996 ‎‡2 NTA|250148552‏
996 ‎‡2 ISNI|0000000059208667‏
996 ‎‡2 BAV|495_360674‏
996 ‎‡2 DNB|170682781‏
996 ‎‡2 NII|DA12787653‏
996 ‎‡2 SUDOC|083015892‏
996 ‎‡2 BNE|XX1201432‏
996 ‎‡2 BNC|981058519984006706‏
996 ‎‡2 RERO|A003280476‏
996 ‎‡2 JPG|500228215‏
996 ‎‡2 DNB|128309695‏
996 ‎‡2 CAOONL|ncf11949646‏
996 ‎‡2 DNB|1057672645‏
996 ‎‡2 LC|n 87822376‏
996 ‎‡2 BNE|XX927078‏
996 ‎‡2 BNC|981058512470606706‏
996 ‎‡2 SUDOC|081057660‏
996 ‎‡2 ARBABN|000045855‏
996 ‎‡2 DNB|1056615745‏
996 ‎‡2 ISNI|000000002376635X‏
996 ‎‡2 ISNI|0000000057881591‏
996 ‎‡2 BNE|XX1690207‏
996 ‎‡2 SUDOC|131796046‏
996 ‎‡2 BNF|12223810‏
996 ‎‡2 BNE|XX943212‏
996 ‎‡2 ISNI|0000000059424749‏
996 ‎‡2 LC|n 83174323‏
996 ‎‡2 ISNI|0000000081457352‏
996 ‎‡2 J9U|987007451179205171‏
996 ‎‡2 BNE|XX943281‏
996 ‎‡2 SUDOC|139159886‏
996 ‎‡2 BNC|981058581222906706‏
996 ‎‡2 ISNI|0000000117115830‏
996 ‎‡2 DNB|1157402224‏
996 ‎‡2 BNE|XX1724535‏
996 ‎‡2 SUDOC|056754248‏
996 ‎‡2 LC|n 81132309‏
996 ‎‡2 BNCHL|10000000000000000011651‏
996 ‎‡2 BNE|XX943225‏
996 ‎‡2 DNB|1056652047‏
996 ‎‡2 BNF|12106474‏
996 ‎‡2 RERO|A003280477‏
996 ‎‡2 SUDOC|248887971‏
996 ‎‡2 ISNI|0000000059997571‏
996 ‎‡2 NII|DA18472892‏
996 ‎‡2 ISNI|0000000061111450‏
996 ‎‡2 BNE|XX1043768‏
996 ‎‡2 BAV|495_225217‏
996 ‎‡2 BNC|981058607594006706‏
996 ‎‡2 LC|n 88646659‏
996 ‎‡2 ICCU|CFIV100571‏
996 ‎‡2 NII|DA09078801‏
996 ‎‡2 ISNI|0000000062470930‏
996 ‎‡2 BNE|XX1074069‏
996 ‎‡2 BNC|981058517510606706‏
996 ‎‡2 LC|n 93103933‏
996 ‎‡2 BNC|981058581063606706‏
996 ‎‡2 DNB|1053301324‏
996 ‎‡2 BNE|XX1020798‏
996 ‎‡2 DNB|1102274240‏
996 ‎‡2 DNB|1057350095‏
996 ‎‡2 DNB|1046847600‏
996 ‎‡2 NUKAT|n 2022002668‏
996 ‎‡2 LC|n 2001039471‏
996 ‎‡2 LC|n 92109150‏
996 ‎‡2 ISNI|0000000110331063‏
996 ‎‡2 SUDOC|142635790‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏